UK markets closed
  • FTSE 100

    -24.59 (-0.37%)
  • FTSE 250

    -140.09 (-0.65%)
  • AIM

    -15.50 (-1.30%)

    +0.0058 (+0.50%)

    +0.0043 (+0.31%)

    -979.08 (-2.68%)
  • CMC Crypto 200

    +13.50 (+1.37%)
  • S&P 500

    +21.74 (+0.57%)
  • DOW

    +180.72 (+0.58%)

    +3.18 (+5.19%)

    -2.30 (-0.13%)
  • NIKKEI 225

    -628.99 (-2.13%)

    -643.63 (-2.15%)
  • DAX

    -23.69 (-0.17%)
  • CAC 40

    +0.59 (+0.01%)

North America Pharmaceutical Contract Research Organization (CRO) Market 2020-2030: Focus on Phase I Trials, Phase II Trials, Phase III Trials & Phase IV Trials

Research and Markets
·4-min read

Dublin, Feb. 12, 2021 (GLOBE NEWSWIRE) -- The "North America Pharmaceutical Contract Research Organization (CRO) Market 2020-2030 by Service, Therapeutic Application, End User, and Country: Trend Forecast and Growth Opportunity" report has been added to's offering.

The North American pharmaceutical CRO market is expected to grow by 7.3% annually in the forecast period and reach $37.61 billion by 2030 driven by the increasing incidence of disease, rising healthcare expenditures, increasing dependence on contract research organizations due to improved efficiency and productivity.

Highlighted with 26 tables and 41 figures, this report is based on comprehensive research of the entire North America pharmaceutical CRO market and all its sub-segments through extensively detailed classifications.

The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify North America pharmaceutical CRO market in every aspect of the classification from perspectives of Service, Therapeutic Application, End User, and Country.

For each key country, detailed analysis and data for annual revenue are available for 2019-2030. The breakdown of key national markets by Service, Therapeutic Application, and End User over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Specifically, potential risks associated with investing in North America pharmaceutical CRO market are assayed quantitatively and qualitatively through a Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.

Key Players (this may not be a complete list and extra companies can be added upon request):

  • Charles River Laboratories

  • CMIC Co. Ltd

  • Covance Inc.

  • Hangzhou Tigermed Consulting Co Ltd

  • ICON Plc

  • IQVIA Holdings Inc.

  • LSK North America Pharma Service Co Ltd

  • Novotech Pty Ltd

  • PAREXEL International Corporation

  • Pharmaceutical Product Development LLC (PPD)

  • PRA Health Sciences Inc.

  • Quanticate Ltd

  • Samsung Bioepis Co. Ltd

  • SGS SA (SGS Life Sciences)

  • Syneos Health Inc.

  • WuXi AppTec Inc.

Key Topics Covered:

1 Introduction
1.1 Industry Definition and Research Scope
1.1.1 Industry Definition
1.1.2 Research Scope
1.2 Research Methodology
1.2.1 Overview of Market Research Methodology
1.2.2 Market Assumption
1.2.3 Secondary Data
1.2.4 Primary Data
1.2.5 Data Filtration and Model Design
1.2.6 Market Size/Share Estimation
1.2.7 Research Limitations
1.3 Executive Summary

2 Market Overview and Dynamics
2.1 Market Size and Forecast
2.1.1 Impact of COVID-19 on World Economy
2.1.2 Impact of COVID-19 on the Market
2.2 Major Growth Drivers
2.3 Market Restraints and Challenges
2.4 Emerging Opportunities and Market Trends
2.5 Porter's Fiver Forces Analysis

3 Segmentation of North America Market by Service
3.1 Market Overview by Service
3.2 CRO for Pre-clinical Development
3.3 CRO for Phase I Trials
3.4 CRO for Phase II Trials
3.5 CRO for Phase III Trials
3.6 CRO for Phase IV Trials
3.7 Laboratory Services
3.8 Consulting Services
3.9 Data Management Services

4 Segmentation of North America Market by Therapeutic Application
4.1 Market Overview by Therapeutic Application
4.2 Infectious Diseases
4.3 Oncology
4.4 Metabolic Disorders
4.5 Cardiovascular Disorders
4.6 Central Nervous System
4.7 Respiratory Disorders
4.8 Gastrointestinal Disorders
4.9 Other Therapeutic Applications

5 Segmentation of North America Market by End User
5.1 Market Overview by End User
5.2 Pharmaceutical & Biopharmaceutical Companies
5.3 Medical Device Companies
5.4 Academic Institutes

6 North America Market 2019-2030 by Country
6.1 Overview of North America Market
6.2 U.S.
6.3 Canada
6.4 Mexico

7 Competitive Landscape
7.1 Overview of Key Vendors
7.2 New Product Launch, Partnership, Investment, and M&A
7.3 Company Profiles

8 Investing in North America Market: Risk Assessment and Management
8.1 Risk Evaluation of North America Market
8.2 Critical Success Factors (CSFs)

For more information about this report visit

CONTACT: CONTACT: Laura Wood, Senior Press Manager For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900